Zyla Life Sciences Finite-Lived Intangible Assets, Gross
Zyla Life Sciences had Finite-Lived Intangible Assets, Gross of $177.22 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2020-05-14
- 2020-03-31: Finite-Lived Intangible Assets, Gross $177.22M.
- 2019-12-31: Finite-Lived Intangible Assets, Gross $182.05M.
- 2019-03-31: Finite-Lived Intangible Assets, Gross $182.05M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2020-03-31 | $177.22M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $182.05M 10-Q · filed 2020-05-14 |
| 2019-03-31 | $182.05M 10-Q · filed 2019-05-17 |